Recognized at the 2018 LMG Life Sciences Awards

September 13, 2018

Paul Hastings was recognized by LMG Life Sciences as Hatch-Waxman Litigation Firm of the Year for 2018. LMG Life Sciences cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.

Get In Touch With Us

Contact Us